A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Thomas Jefferson University
Eli Lilly and Company
Cogent Biosciences, Inc.
Eli Lilly and Company
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Kedrion S.p.A.
Ossium Health, Inc.
Memorial Sloan Kettering Cancer Center